1. Hippocampal novelty activations in schizophrenia: Disease and medication effects
- Author
-
Ronald Chin, Carol A. Tamminga, Binu P. Thomas, Perry Mihalakos, Alison R. Preston, Anthony D. Wagner, and Kenneth Youens
- Subjects
Adult ,Male ,medicine.medical_specialty ,Psychosis ,medicine.medical_treatment ,Hippocampus ,Hippocampal formation ,behavioral disciplines and activities ,Neuroimaging ,Cortex (anatomy) ,medicine ,Humans ,Psychiatry ,Antipsychotic ,Biological Psychiatry ,Functional Neuroimaging ,Novelty ,Recognition, Psychology ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,Psychiatry and Mental health ,medicine.anatomical_structure ,Schizophrenia ,Case-Control Studies ,Parahippocampal Gyrus ,Female ,Psychology ,Neuroscience ,Antipsychotic Agents - Abstract
We examined hippocampal activation in schizophrenia (SZ) with fMRI BOLD in response to the presentation of novel and familiar scenes. Voxel-wise analysis showed no group differences. However, anatomical region-of-interest analyses contrasting normal (NL), SZ-on-medication (SZ-ON), SZ-off-medication (SZ-OFF) showed substantial differences in MTL-based novelty responding, accounted for by the reduction in novelty responses in the SZ-OFF predominantly in the anterior hippocampus and parahippocampal cortex. These differences in novelty-based activation in the SZ-OFF group represent disease characteristics of schizophrenia without confounding effects of antipsychotic medication and illustrate the tendency of antipsychotic drug treatment to improve memory functions in schizophrenia.
- Published
- 2012
- Full Text
- View/download PDF